Foldrx Pharmaceuticals' Series B Round

Foldrx Pharmaceuticals raised a round of funding on May 19, 2006.

FoldRx is a leader in the discovery and development of disease-modifying drug therapies for diseases of protein misfolding and amyloidosis.…

Articles about Foldrx Pharmaceuticals' Series B Round: